Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Sutro Biopharma PE Ratio 2017-2020 | STRO

Current and historical p/e ratio for Sutro Biopharma (STRO) from 2017 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sutro Biopharma PE ratio as of July 10, 2020 is 0.00.
  
Sutro Biopharma PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-10 9.02 0.00
2020-03-31 10.20 $-2.64 0.00
2019-12-31 11.00 $-2.42 0.00
2019-09-30 9.09 $-1.78 0.00
2019-06-30 11.38 $-22.48 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.210B $0.043B
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $146.497B 16.13
Bristol Myers Squibb (BMY) United States $129.946B 10.86
Gilead Sciences (GILD) United States $95.734B 12.41
CSL (CSLLY) Australia $90.156B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.344B 52.49
Regeneron Pharmaceuticals (REGN) United States $68.306B 26.33
Illumina (ILMN) United States $54.427B 55.93
Biogen (BIIB) United States $45.510B 7.79
Seattle Genetics (SGEN) United States $30.180B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $25.051B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.030B 10.32
Moderna (MRNA) United States $23.242B 0.00
BioMarin Pharmaceutical (BMRN) United States $22.796B 206.66
Genmab (GMAB) Denmark $22.796B 18.77
Incyte (INCY) United States $22.772B 0.00
Genmab (GNMSF) Denmark $21.669B 64.33
Alnylam Pharmaceuticals (ALNY) United States $18.717B 0.00
BioNTech SE (BNTX) Germany $15.920B 0.00
BeiGene (BGNE) Cayman Islands $15.246B 0.00
Exact Sciences (EXAS) United States $13.805B 0.00
Sarepta Therapeutics (SRPT) United States $13.165B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Galapagos (GLPG) Belgium $12.513B 36.81
ARGENX SE-ADR (ARGX) Netherlands $11.776B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.918B 26.87
Bio-Techne Corp (TECH) United States $10.412B 68.79
QIAGEN (QGEN) Netherlands $10.319B 30.01
Immunomedics (IMMU) United States $9.541B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.642B 0.00
Guardant Health (GH) United States $8.059B 0.00
Exelixis (EXEL) United States $7.648B 26.82
SWEDISH ORP BIO (BIOVF) Sweden $6.750B 16.79
Repligen (RGEN) United States $6.597B 115.72
Ascendis Pharma (ASND) Denmark $6.573B 0.00
Adaptive Biotechnologies (ADPT) United States $5.828B 0.00
Vir Biotechnology (VIR) United States $5.743B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.544B 119.29
Novavax (NVAX) United States $5.469B 0.00
Acceleron Pharma (XLRN) United States $5.382B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.146B 0.00
Reata Pharmaceuticals (RETA) United States $5.132B 0.00
Zai Lab (ZLAB) China $5.053B 0.00
Mirati Therapeutics (MRTX) United States $5.016B 0.00
Emergent Biosolutions (EBS) United States $4.940B 32.38
MyoKardia (MYOK) United States $4.335B 0.00
Global Blood Therapeutics (GBT) United States $4.334B 0.00
Blueprint Medicines (BPMC) United States $4.279B 0.00
MorphoSys AG (MOR) Germany $4.266B 33.09
China Biologic Products (CBPO) China $4.198B 23.34
Momenta Pharmaceuticals (MNTA) United States $4.037B 0.00
Amicus Therapeutics (FOLD) United States $4.002B 0.00
Halozyme Therapeutics (HALO) United States $3.789B 0.00
NeoGenomics (NEO) United States $3.776B 275.77
Inovio Pharmaceuticals (INO) United States $3.696B 0.00
Bluebird Bio (BLUE) United States $3.561B 0.00
Arena Pharmaceuticals (ARNA) United States $3.318B 0.00
Alkermes (ALKS) Ireland $3.126B 61.53
Deciphera Pharmaceuticals (DCPH) United States $3.030B 0.00
Insmed (INSM) United States $2.813B 0.00
Fate Therapeutics (FATE) United States $2.739B 0.00
Denali Therapeutics (DNLI) United States $2.739B 0.00
Amarin (AMRN) Ireland $2.590B 0.00
PHARMA MAR SA (PHMMF) Spain $2.430B 0.00
Twist Bioscience (TWST) United States $2.242B 0.00
Principia Biopharma (PRNB) United States $2.116B 0.00
UniQure (QURE) Netherlands $2.057B 0.00
Viela Bio (VIE) United States $1.982B 0.00
Eidos Therapeutics (EIDX) United States $1.859B 0.00
Ligand Pharmaceuticals (LGND) United States $1.847B 71.91
Alector (ALEC) United States $1.841B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.840B 0.00
Editas Medicine (EDIT) United States $1.816B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.698B 0.00
Sorrento Therapeutics (SRNE) United States $1.690B 0.00
I-Mab (IMAB) China $1.683B 0.00
Intra-Cellular Therapies (ITCI) United States $1.642B 0.00
Adverum Biotechnologies (ADVM) United States $1.596B 0.00
Epizyme (EPZM) United States $1.532B 0.00
Mesoblast (MESO) Australia $1.517B 0.00
Cytokineticsorporated (CYTK) United States $1.516B 0.00
Zymeworks (ZYME) Canada $1.511B 0.00
Sangamo Therapeutics (SGMO) United States $1.506B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.485B 0.00
Mersana Therapeutics (MRSN) United States $1.444B 0.00
Revance Therapeutics (RVNC) United States $1.410B 0.00
Zealand Pharma (ZEAL) Denmark $1.410B 0.00
REGENXBIO (RGNX) United States $1.385B 0.00
Beam Therapeutics (BEAM) United States $1.376B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NantKwest (NK) United States $1.359B 0.00
Arvinas (ARVN) United States $1.357B 0.00
Akcea Therapeutics (AKCA) United States $1.315B 0.00
NGM Biopharmaceuticals (NGM) United States $1.304B 0.00
Coherus BioSciences (CHRS) United States $1.271B 8.88
Intellia Therapeutics (NTLA) United States $1.223B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.201B 0.00
Arcus Biosciences (RCUS) United States $1.125B 0.00
Compugen (CGEN) Israel $1.085B 0.00
Athenex (ATNX) United States $1.017B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.984B 0.00
Alcobra (ARCT) United States $0.933B 0.00
VBI Vaccines (VBIV) United States $0.904B 0.00
Retrophin (RTRX) United States $0.865B 0.00
Heska (HSKA) United States $0.863B 0.00
Myriad Genetics (MYGN) United States $0.855B 44.12
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.825B 0.00
Pharming Group (PHGUF) Netherlands $0.817B 21.75
Dynavax Technologies (DVAX) United States $0.798B 0.00
Morphic Holding (MORF) United States $0.787B 0.00
Intrexon (PGEN) United States $0.780B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.746B 0.00
Vericel (VCEL) United States $0.724B 133.83
ZIOPHARM Oncology Inc (ZIOP) United States $0.722B 0.00
Castle Biosciences (CSTL) United States $0.719B 0.00
Cellectis S.A (CLLS) France $0.719B 0.00
Frequency Therapeutics (FREQ) United States $0.713B 0.00
Codexis (CDXS) United States $0.676B 0.00
Kadmon Holdings (KDMN) United States $0.674B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.636B 0.00
Agenus (AGEN) United States $0.634B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.627B 5.37
Autolus Therapeutics (AUTL) United Kingdom $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
AnaptysBio (ANAB) United States $0.579B 0.00
MiMedx (MDXG) United States $0.569B 0.00
Kala Pharmaceuticals (KALA) United States $0.554B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.554B 0.00
Athersys (ATHX) United States $0.552B 0.00
Cel-Sci (CVM) United States $0.538B 0.00
Syros Pharmaceuticals (SYRS) United States $0.525B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.516B 0.00
Clovis Oncology (CLVS) United States $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.502B 16.14
NextCure (NXTC) United States $0.492B 0.00
UROGEN PHARMA (URGN) United States $0.488B 0.00
AC Immune SA (ACIU) Switzerland $0.479B 0.00
Scholar Rock Holding (SRRK) United States $0.473B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.466B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.462B 0.00
DBV Technologies S.A (DBVT) France $0.461B 0.00
MeiraGTx Holdings (MGTX) United States $0.457B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
OSMOTICA PHARM (OSMT) United States $0.452B 0.00
Protagonist Therapeutics (PTGX) United States $0.447B 0.00
Geron (GERN) United States $0.437B 0.00
BioDelivery Sciences (BDSI) United States $0.423B 22.21
Precision BioSciences (DTIL) United States $0.419B 0.00
Merus (MRUS) Netherlands $0.418B 0.00
Puma Biotechnology (PBYI) United States $0.409B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.395B 0.00
Avid Bioservices (CDMO) United States $0.393B 0.00
CytomX Therapeutics (CTMX) United States $0.391B 0.00
MannKind (MNKD) United States $0.379B 0.00
Kamada (KMDA) Israel $0.377B 15.69
Albireo Pharma (ALBO) United States $0.377B 0.00
WAVE Life Sciences (WVE) Singapore $0.354B 0.00
Affimed (AFMD) Germany $0.336B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 6.53
Seres Therapeutics (MCRB) United States $0.327B 0.00
PDL BioPharma (PDLI) United States $0.320B 280.50
ChromaDex (CDXC) United States $0.314B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.306B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Prometic Life Sciences (LMNL) Canada $0.293B 0.00
Cellular Biomedicine (CBMG) United States $0.289B 0.00
Pfenex (PFNX) United States $0.281B 0.00
Menlo Therapeutics (MNLO) United States $0.280B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
IBio (IBIO) United States $0.263B 0.00
Celldex Therapeutics (CLDX) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.252B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.244B 0.00
Dyadic (DYAI) United States $0.240B 0.00
Verastem (VSTM) United States $0.236B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.229B 0.00
Selecta Biosciences (SELB) United States $0.229B 0.00
IVERIC Bio (ISEE) United States $0.227B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.225B 0.00
Fortress Biotech (FBIO) United States $0.224B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
Pluristem Therapeutics (PSTI) Israel $0.216B 0.00
Aduro Biotech (ADRO) United States $0.216B 0.00
Liquidia Technologies (LQDA) United States $0.211B 0.00
XOMA (XOMA) United States $0.210B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.208B 3.13
Exicure (XCUR) United States $0.207B 0.00
Aptinyx (APTX) United States $0.205B 0.00
GENFIT S.A (GNFT) France $0.205B 0.00
Strongbridge Biopharma (SBBP) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.177B 0.00
Bellus Health (BLU) Canada $0.177B 0.00
Theratechnologies (THTX) Canada $0.176B 0.00
Trevena (TRVN) United States $0.171B 0.00
Aytu Bioscience (AYTU) United States $0.165B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
TELA Bio (TELA) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Cerecor (CERC) United States $0.153B 0.00
Kindred Biosciences (KIN) United States $0.153B 0.00
Applied Genetic Technologies (AGTC) United States $0.150B 0.00
Cyclerion Therapeutics (CYCN) United States $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
VolitionRX (VNRX) United States $0.144B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
PHASEBIO PHARMA (PHAS) United States $0.136B 0.00
Celyad SA (CYAD) Belgium $0.132B 0.00
Lumos Pharma (LUMO) United States $0.132B 0.00
Biofrontera AG (BFRA) Germany $0.131B 0.00
Oncobiologics (OTLK) United States $0.130B 0.00
Arbutus Biopharma (ABUS) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.127B 0.00
Palatin Technologies (PTN) United States $0.121B 3.10
Lineage Cell Therapeutics (LCTX) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Celsion (CLSN) United States $0.114B 0.00
Protalix BioTherapeutics (PLX) Israel $0.113B 0.00
AIT Therapeutics (XAIR) United States $0.113B 0.00
AquaBounty Technologies (AQB) United States $0.112B 0.00
Eton Pharmaceuticals (ETON) United States $0.106B 0.00
Unum Therapeutics (UMRX) United States $0.103B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Cardiff Oncology (CRDF) United States $0.094B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.094B 0.00
Windtree Therapeutics (WINT) United States $0.093B 0.00
Cocrystal Pharma (COCP) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.087B 0.00
Adocia (ADOCY) France $0.080B 0.00
Organovo Holdings (ONVO) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
Catalyst Biosciences (CBIO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.060B 0.00
AnPac Bio-Medical Science (ANPC) China $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Soligenix (SNGX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.051B 0.00
CollPlant Holdings (CLGN) Israel $0.051B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Curis (CRIS) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
Acorda Therapeutics (ACOR) United States $0.035B 0.00
Advaxis (ADXS) United States $0.035B 0.00
OvaScience (MLND) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.031B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
Cesca Therapeutics (THMO) United States $0.031B 0.00
Spherix (AIKI) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.028B 0.00
BioPharmX (TMBR) United States $0.027B 0.00
Evogene (EVGN) Israel $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
IMMURON (IMRN) Australia $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
BioCardia (BCDA) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00